TRI-74

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTRI-74
Drug Alias NameTRI-25TRI-74
ClassificationSmall molecules
Mechanisms of ActionKallikreins inhibitorsTrypsin inhibitorsFactor IIa inhibitors +[6] 
TargetsProthrombinUrokinase plasminogen activatorTrypsin +[5] 
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Thrombosis Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Thrombosis Research Institute
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A